Tell Congress to Let Medicare Negotiate with Big Pharma

Price-gouging and patent monopolies are behind Big Pharma’s obscene profits.

Even so, with its vast purchasing power, Medicare should be able to negotiate lower prices — much lower.

But Medicare is prohibited from doing exactly that by a 2003 law that the pharmaceutical industry and its legion of lobbyists in D.C. rammed through Congress.

So our nation’s seniors pay at least $16 billion more per year than they would if Medicare could negotiate fair prices with the drug companies. And many simply go without medications they need.

Tell Congress:

Let Medicare negotiate lower prices with the drug companies.